Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Pitt Researchers Find Promising Candidate Protein For Cancer Prevention Vaccines
Researchers at the University of Pittsburgh School of Medicine have learned that some healthy people naturally developed an immune response against a protein that is made in excess levels in many cancers, including breast, lung, and head and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in high-risk individuals.
generic viagra online
Analysis Of Drug-Eluting Stents Data Demonstrates Safety, Efficacy In On-And-Off-Label Use
The Cardiovascular Research Foundation (CRF) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) were published online June 15 in the journal Circulation. The study also compared the rates of myocardial infarction (MI) and target vessel revascularization (TVR).
News of the day
What Is Cystitis? What Causes Cystitis?
Cystitis refers to inflammation of the lining of the bladder. It usually occurs when the normally sterile urethra and bladder (lower urinary tract) are infected by bacteria and become irritated and inflamed. Cystitis is fairly common and can affect both men and women and people of all ages. However, it is more common in women.
Oncology

Cegedim Dendrite Launches Innovative COUNTERxFEIT DETECT Program

Cegedim Dendrite announced the launch of COUNTERxFEIT DETECT, a new offering that will assist pharmaceutical companies in identifying counterfeit product and determining where it entered their United States supply chains. Cegedim Dendrite is the leading provider of compliance technology solutions and services in the pharmaceutical industry. Counterfeit medicines represent a significant public health and safety issue for consumers. It also poses serious business and financial risks for manufacturers, including possible liability issues, lost revenue, erosion of brand confidence and negative public perception. COUNTERxFEIT DETECT is designed for pharmaceutical companies that need to identify and determine the of counterfeit, contaminated or adulterated product. Cegedim Dendrite facilitates this by coordinating the purchase of non-controlled, finished drug products from contract manufacturers or distributors, using an independent pharmaceutical buyer. The product is shipped to a testing facility or the pharmaceutical company"s analytical lab, where the product is analyzed. "Drug counterfeiting is a concern in the pharmaceutical industry with estimates indicating that upward of 8% of pharmaceutical medicines worldwide may be counterfeit," explained Bill Buzzeo, Cegedim Dendrite Vice President and General Manager, Compliance Solutions and OneKey. "As part of their anti-counterfeiting programs, pharmaceutical companies should acquire finished drug products within the supply chain for analysis and testing to ensure their quality. We seamlessly facilitate that process, and as far as we know, we"re the only company that offers this type of program." Cegedim Dendrite"s independent purchasing of finished drug product takes the burden off the pharmaceutical company"s internal res. COUNTERxFEIT DETECT is fully secure and includes appropriate audit trail documentation that provides insight into the full acquisition chain associated with the independent pharmacy"s purchase. "If an independent party is making the purchase," said Buzzeo, "the pharmaceutical company can better show that they had a random sample for testing and that the process was not tainted by anyone internally with false motive." Cegedim Dendrite has been providing comprehensive compliance solutions to a broad range of pharmacy clients for 20 years. The company employs former state and federal regulators whose firsthand experience with compliance, fraud and abuse issues enable them to develop real-world prevention programs. About Cegedim Dendrite Cegedim Dendrite is the life sciences industry"s leading provider of Customer Relationship Management (CRM) solutions. Pharmaceutical by design, the company"s innovative business solutions and global reach incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Dendrite enables more than 200,000 users in many of the world"s top companies to stay ahead of market challenges. Cegedim Dendrite also provides sales, marketing and regulatory compliance solutions in more than 80 countries. Cegedim Dendrite is part of the France-based Cegedim S.A. Group. To learn more, please visit http://www.cegedimdendrite.com. Cegedim


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009